Basic Information
| LncRNA/CircRNA Name | AK130076 |
| Synonyms | NA |
| Region | GRCh38_10:87938883-87939351 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | high grade ovarian serous cancer |
| ICD-0-3 | C56 |
| Methods | Microarray, qPCR etc. |
| Sample | high-grade ovarian serous cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | The results demonstrated that FAS-AS1, AK130076, RP11-199F11.2 and AC093818.1 were upregulated and GTSE1-AS3 was downregulated in high-grade ovarian serous cancer tissues compared with healthy fallopian tube tissues. |
| Pubmed ID | 29577163 |
| Year | 2018 |
| Title | Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high-grade ovarian serous cancer. |
External Links
| Links for AK130076 | GenBank HGNC NONCODE |
| Links for high grade ovarian serous cancer | OMIM COSMIC |